- Home
- KNDI vs ARMP Comparison
KNDI vs ARMP Comparison
Compare KNDI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- ARMP
- Stock Information
- Founded
- KNDI 2002
- ARMP N/A
- Country
- KNDI China
- ARMP United States
- Employees
- KNDI N/A
- ARMP N/A
- Industry
- KNDI Auto Manufacturing
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KNDI Consumer Discretionary
- ARMP Health Care
- Exchange
- KNDI Nasdaq
- ARMP Nasdaq
- Market Cap
- KNDI 109.2M
- ARMP 104.3M
- IPO Year
- KNDI N/A
- ARMP N/A
- Fundamental
- Price
- KNDI $1.22
- ARMP $3.17
- Analyst Decision
- KNDI
- ARMP Strong Buy
- Analyst Count
- KNDI 0
- ARMP 1
- Target Price
- KNDI N/A
- ARMP $9.00
- AVG Volume (30 Days)
- KNDI 124.0K
- ARMP 8.2K
- Earning Date
- KNDI 11-17-2025
- ARMP 11-12-2025
- Dividend Yield
- KNDI N/A
- ARMP N/A
- EPS Growth
- KNDI N/A
- ARMP N/A
- EPS
- KNDI N/A
- ARMP N/A
- Revenue
- KNDI $104,035,613.00
- ARMP $6,868,000.00
- Revenue This Year
- KNDI N/A
- ARMP $8.43
- Revenue Next Year
- KNDI N/A
- ARMP N/A
- P/E Ratio
- KNDI N/A
- ARMP N/A
- Revenue Growth
- KNDI N/A
- ARMP 84.67
- 52 Week Low
- KNDI $0.89
- ARMP $0.90
- 52 Week High
- KNDI $1.81
- ARMP $3.29
- Technical
- Relative Strength Index (RSI)
- KNDI 42.52
- ARMP 60.67
- Support Level
- KNDI $1.21
- ARMP $3.08
- Resistance Level
- KNDI $1.24
- ARMP $3.24
- Average True Range (ATR)
- KNDI 0.07
- ARMP 0.10
- MACD
- KNDI 0.00
- ARMP 0.00
- Stochastic Oscillator
- KNDI 40.48
- ARMP 65.47
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.